Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Rituximab 500. (CDM 4082120) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 9, 2026 , from http://ppman.hank.ai/transparency/procedure/4082120/by-state?code_type=CDM
“Rituximab 500. (CDM 4082120) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/4082120/by-state?code_type=CDM. Accessed
October 9, 2026 .
“Rituximab 500. (CDM 4082120) by State,” HANK Price Transparency ,
accessed October 9, 2026 ,
http://ppman.hank.ai/transparency/procedure/4082120/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
4082120 — Rituximab 500.
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$3,396
National median
$44 – $5,394
IQR (p25 – p75)
4
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 4082120 (CDM), with interquartile range
State Median p25 p75
MI $19 $19 $19
ND $3,396 $53 $6,184